"Gistak": ntuziaka maka ojiji, nkọwa na reviews

Dọkịta na n'ikuku ndị mmadụ dị iche iche na-eme mkpesa. Ọtụtụ mgbe, ọ bụ n'ihi nsogbu na eriri afọ tract. People taa ọtụtụ ugboro aba na-esochi nke ihe ha na-eri, dị ka a na ya pụta, na-ata ahụhụ si na ọrịa na-eji ime ihe obere ugboro ugboro. Modern nri, nri ngwa ngwa, na ụdị nile nke ibe na crackers nwere ọtụtụ nri e ji esiji ákwà, nwekwara ndị ọzọ na-adịghị mma utịp ke afo Efrata. N'ihi ya, e mgbu ma ọ bụ peptic ọnyá afọ ọrịa. Otu n'ime ọtụtụ ndị na-kenyere ọgwụ maka ọgwụgwọ nke pathologies nke digestive tract bụ a "Gistak". Ntuziaka maka ojiji, analogs na nzaghachi banyere nke a ọgwụ ga-atụle n'ihu.

Olee otú ọgwụ

Mmasị ọ bụla ngwugwu nke ọgwụ "Gistak" ntụziaka ntuziaka. The foto n'okpuru na-egosi ihe ya anya ka mbụ nkwakọ ngwaahịa nke ọgwụ.

Drug "Gistak" na-ezo aka a ọgwụ na-eme ihe iji kpasuo a ọnụ mmepụta nke gastric ihe ọṅụṅụ, proportionally mbenata ọrụ na ego nke pepsin. N'ọrụ umi nke nkwadebe - ranitidine - ezo aka parietal cell histamine H2 ihe nnabata. Ọ bụ ike inhibit secretion nke acid ke afo glands, ebelata ihe mgbu. Ediyarade nke nrekasi obi na ya ugboro ole nke omume ebelata budata. The mucous akpụkpọ ahụ na afo activates ya na-echebe Njirimara, gwọọ ọnyá ọnya, nkịtị ụda nke ala gastroesophageal sphincter.

Action "Gistak" ọgwụ ọjọọ ruo awa iri na abụọ. Ozugbo i weere na nkà mmụta ọgwụ, na kacha ịta nke nọ n'ọrụ umi a na-enweta n'ụzọ nkịtị adịghị emetụta absorption nke "Gistak" nkwadebe na a di na nwunye nke awa, na nri.

Excretion nke ọgwụ si ahụ na-rụrụ site na akụrụ ya. A obere akụkụ a tọhapụrụ n'ụdị metabolic ngwaahịa, ọ bụ banyere 8%. Banyere 40% na-anyụpụ na mmamịrị, ma ọ bụrụ na ọgwụ a na-gafere ọnụ, na 70% mgbe ndinọ parenterally. Ndị fọdụrụ atara site excrement.

Ọ ga-kwuru na mgbe a na-ahụ mgbe nile ndokwa ọgwụ na onunu ogwu maka 4-6 izu ọnyá afọ na-agwọ ọrịa emee. A n'ikuku mmezi dosing n'abalị ebelata nlọghachite nke ọrịa.

Idepụta ọgwụ "Gistak"

Ntuziaka maka ojiji na-egosi a ọrịa n'ihi na nke ọgwụ na-ndinọ maka ọgwụgwọ na mgbochi:

• Ọnyá ọnya dị iche iche eriri afọ tract.
• Ọnya mere na postoperative oge.
• Maka ọgwụgwọ nke reflux oesophagitis na ahụ efe nke ọrịa ihe mgbaàmà.
• Gastroesophageal reflux ọrịa.
• Ellison - Zollinger.
• Epigastric mgbu ma ọ bụ retrosternal.
• Agba ọbara na afo na eriri afọ.
• Peptic, na-agba ọbara ọnyá afọ na ntighari ọbara ọgbụgba.

Ọzọkwa ọgwụ ji ná Nkụnwụ maka ọrịa ndị nwere a elu n'ihe ize ndụ nke ntọhapụ nke acidic afo ọdịnaya.

Ka ihe i nwere ike ime ka "Gistak"? Ntuziaka maka ojiji e dere ozi na contraindications. Ka anyị tụlee ha n'okpuru ebe a.

Na-ekwesịghị iri "Gistak"

Tupu ịmalite iji ọ bụla ọgwụ, ọ dị mkpa na-enyocha nchịkọta. Nke a na-emetụta nkwadebe "Gistak". Ntuziaka na ojiji nke megide-egosi ndị na-esonụ:

• Hypersensitivity ọ bụla mgwa nke ọgwụ.
• Kweghị ka nkà mmụta ọgwụ ụmụaka na-erubeghị afọ iri na abụọ.
• Na oke-elekọta gị n'ụlọnga ndinọ ka ọrịa na hepatic imeju na gbasara akụrụ odida.

Drug ọgwụ n'oge ime na lactation

Na-amụ nke nọ n'ọrụ umi ranitidine ọ hụrụ na ọ bụ ike ịgafe Plasenta. N'oge ime na ọgwụgwọ were nke ọgwụ adịghị a ezighị ezi mmetụta na oru na nwa ebu n'afọ na mmepe. The iji ọgwụ ọjọọ eme "Gistak" ka nwanyị dị ime bụ ekwe omume, ma ọ bụrụ na ọ dị mkpa ka uru ga karịa ike n'ihe ize ndụ ka nke nwa ebu n'afọ.

Ọzọkwa, ọgwụ na-enwe ike ime (albeit obere obere) na mmiri ara. Mgbe oge nke ọgwụgwọ "Gistakom"-ezere ara.

Nwere ike ime ka ndị na-esonụ ọgwụgwụ: idepụta a ọgwụ ọjọọ, "Gistak" ime na lactating ekwe omume naanị na ikpe nke oké mkpa.

Ọnụọgụ ọgwụ forms na ọgwụ

Nkwadebe "Gistak" dị na mbadamba ụdị. Ha na-acha ọcha, ubé convex udi, ntekwasa, na-akara na otu akụkụ HISTAC 150, na ndị ọzọ -storony RANBAXY. Otu mbadamba nwere ranitidine hydrochloride 150 mg.

Iji ọgwụ adịghị emerụ ahụ ike, ọ ga-amụ tupu ewere "Gistak" ntụziaka ntuziaka. The onunu ogwu nke ọgwụ na-kenyere a dọkịta, nwere ike gafere ya.

Mbadamba ọgwụ n'ihi na ndị okenye na ndị na-esonụ Dosages: 150 mg nke ụtụtụ na mgbede. Na ọnụnọ nke onya duodenum 12 omume otu ngwa nke 300 mg na alakpu ụra.

The ọgwụgwọ nke peptic ọnyá afọ na ọrịa bụ a ihe 4 izu. Ọ bụrụ na ọ dịghị mma emee, ndị ọgwụ ugboro ugboro ọnụego.

Na ntighari peptic ọnyá afọ ọgwụ kenyere ka a mgbochi ụfọdụ mgbe agwọ ọrịa natara, dị ka e gosiri site ọgwụ "Gistak" ntụziaka ntuziaka. Mbadamba mkpa ka a na otu ugboro n'ụbọchị, na-alakpu ụra, na ego nke 150 mg. Prophylactic dose n'oge n'oge a kara exacerbation nke gastric ọrịa na 150 mg kwa ụbọchị.

Reflux esophagitis erosive esophagitis na mgbe chọrọ ibu Dosages ruo 150 mg ugboro anọ kwa ụbọchị. The ọgwụgwọ dịruru ruo ọnwa abụọ.

Zollinger - Ellison nwekwara-achọ ihe ụba onunu ogwu - 150 mg 3 ugboro n'ụbọchị. Ọ bụrụ na ọ dị mkpa, ndị dose nwere ike mụbara. Studies gosiri na ọrịa na-ewere 6 grams nke ọgwụ kwa ụbọchị (kacha anabata dose), ọ na-ọma na-anabata.

Tupu ị nwere ịbanye ná Nkụnwụ Ahụ, iji gbochie Mendelson si syndrome, lee "Gistak" - 150 mg kwa ụbọchị tupu ịwa ahụ, na mgbede, na awa abụọ tupu ịwa ahụ.

Children nwere ike ọgwụ na a 12 nọ n'agbata afọ, na onunu ogwu dabeere ahu arọ:

• Peptic ọnyá afọ - si 4 ka 8 mg kwa kilogram arọ ahụ kwa ụbọchị.
• Gastroesophageal reflux ọrịa - si 5 na 10 mg kwa kilogram nke ahu aro kwa ụbọchị.

Ọ bụrụ na e nwere abnormalities na akụrụ na-atụ aro dose bụ 150 mg kwa ụbọchị.

Mmetụta nke ọgwụ

Mkpa ka ị mara ihe nwere ike na-achọghị mmetụta mgbe na-ewere ọgwụ ọjọọ, "Gistak". Ntuziaka maka ojiji nke mmetụta nke ọgwụ kọwara dị ka ndị a:

• Leukopenia, agranulocytosis, thrombocytopenia nloghachi.
• Nfụkasị Jeremaya.
• Iro ụra, ahụ mgbakasị, ike ọgwụgwụ, tinnitus.
• Isi ọwụwa.
• Vasculitis, bradycardia, asystole.
• Afọ ọsịsa, afọ ntachi, akọrọ ọnụ.
• Reversible ịba ọcha n'anya.
• Skin rashes.
• Nnukwu nephritis, myalgia, erughị ala na ara.

Ọ ga-kwuru na ọtụtụ n'ime ọgwụ na-nnọọ nke ọma anabata ọrịa. N'ihe banyere ọgwụ oghom ihe dị mkpa onunu ogwu Mbelata ma ọ bụ agugo nke ọgwụ na ahu ọrụ weghachiri eweghachi.

ọgwụ ovadozu

Ekwela gafere na-atụ aro dose "Gistak" ọgwụ ọjọọ. Ntuziaka maka ojiji (ọgwụ ọjọọ nkọwa nyere n'elu) adọ aka ná ntị nke a kwe omume ovadozu. N'ọnọdụ dị otú ahụ ikekwe ụba oghom ihe. Ọ na-atụ aro na-akpọ a dọkịta. Dị ka ihe na adjunct ọgwụgwọ na-atụ aro ịrụ hemodialysis.

Dị ka "Gistak" interacts na ndị ọzọ ọgwụ ọjọọ na ịṅụbiga mmanya

The ọgwụ ike belata ma ọ bụ dịkwuo ha arụmọrụ, nakwa dị ka neutralize ihe nke ọgwụ ụfọdụ. Otu kwesịrị ịkpachara anya, na-ewere na njikọ na ndị ọzọ ọgwụ ọjọọ "Gistak". Ntuziaka maka ojiji nke ụfọdụ atụmatụ na-egosi a ọgwụ na mmekọrịta:

• Action "Gistaka" adịghị amụba ma ọ bụ ibelata na ịdị na-esonụ ọgwụ ọjọọ: "Diazepam" "Lidocaine," "Theophylline".
• Prothrombin oge gbanwere mgbe nkwonkwo ọgwụgwọ nke coumarin anticoagulants. Ọ dị mkpa ịkpachara anya ya.
• Imekotaotuugbo ojiji nke ranitidine na procainamide na ya-arụsi ọrụ metabolite nwere ike belata ha excretion. Nke a ga-abuana na-abawanye nke a umi ke plasma.
• Mụbara absorption mgbe eji ọnụ na "Gistakom" ndị na-esonụ ọgwụ ọjọọ: «triazolam», "Midazolam", "Glipizide".
• Belata absorption nke ndị na-esonụ ọgwụ ọjọọ: "Delavirdine," "Ketoconazole", "atazanavir", "Gefitinib."
• "Sucralfate" na a onunu ogwu uku 2 g, ga-a na otu nkeji nke 2 awa bụghị belata irè nke ranitidine.
• Ọgwụ ndị na-ebelata ụmị ọkpụkpụ, enwekwu ihe ize ndụ nke neutropenia.

Ọ bụrụ na concomitant ojiji nke mmanya na "Gistaka" larịị nke mmanya na ọbara adahade. Nrụpụta na-ebelata n'oge ise siga.

Special ntuziaka maka ojiji nke ọgwụ

• Mgbe inweta "Gistak" ọgwụ ọjọọ ya kwesịrị izere ọrụ chọrọ ntị ma na management nke iga na usoro.
• Ná mmalite nke ọgwụgwọ a ga-enyocha ma achị si cancer nke afo, ka ọgwụ na-ekpuchi ihe mgbaàmà. Ọ na-achọ uche pụrụ iche na nzube ọgwụ merela agadi ọrịa na ọ isi gbasara akụrụ ọrụ.
• Na agadi ọrịa na ẹdude ọgwụ ọnọdụ dị ka ọrịa shuga, ala ala akpa ume ọrịa, nwere ike ịzụlite oyi baa.
• Anya prescribers ọrịa na mkpọchị imeju ọrụ, dị ka "Gistak" metabolized ke idem.

Drug analogues "Gistak"

N'ihi na dị iche iche, ụfọdụ ọrịa na-amanye iji ọgwụ na yiri mejupụtara. Site analogues na-agụnye:

• "Zoran".
• "Ranitidine".
• "Zantac".
• "Atsilok".
• "Ulran".
• "Ranitidine-Agos".
• "Ranitidine-Verein".
• "Ranitidine-Lect."

Tupu ị dochie mbụ na ya analọg, ị kwesịrị ịkpọ gị dọkịta.

Nyocha nkwadebe

The ọgwụ na-kenyere dọkịta ma mgbochi na ọgwụgwọ nke gastric ọrịa. Iji nweta chọrọ ọgwụgwọ mmetụta na iji gbochie oghom Jeremaya mere ka ojiji nke ọgwụ ọjọọ, "Gistak 'ntuziaka maka ojiji, Ibọrọ ga-atụle. N'ihi ya, ọrịa kọrọ na ọgwụ na-adịghị gụnyere ndepụta nke oké ọnụ, ma ọ na-arụ ọrụ nke ukwuu n'ụzọ dị irè.

Ọtụtụ na-ekwu na igbu ndị ọnyá afọ na iji ọgwụ ọjọọ. The results na-ezi ihe, ọ dighi oghom ihe. The na nkà mmụta ọgwụ kabinet bụ mgbe uru-edebe ihe a ọgwụ.

Ọrịa na-eji ọgwụ maka ọgwụgwọ nke mgbu na-arụpụta na-anọgide na-eju eju. Oghom ihe dị ụkọ. The ọgwụ dị. Ma i nwere ike buru maka mgbochi. N'ihi ya, ọnụ ọgụgụ nke ndị nlọghachi nke ọrịa na-ukwuu belata.

Ejila ọgwụ enweghị n'ịgakwuru dọkịta gị. Nke a bụ eziokwu ọbụna ihe ndị kasị-enweghị ihe ọjọọ na mbụ ilekiri. Health - bụ ihe kasị ọnụ ahịa a nwoke nwere ike, na-elekọta ya.